[AMRS] Amyris, Inc.


Type of security: Stock

Sector: Basic Industries

Industry: Major Chemicals

Market Capitalization: 84.47 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 0.71 Change: 0.03 (4.28%)
Ext. hours: 0.7 Change: -0.01 (-1.22%)

chart AMRS

Refresh chart

Strongest Trends Summary For AMRS

AMRS is in the long-term down -100% below S&P in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Amyris, Inc., a renewable products company, provides various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. It builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons. The company produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products. It also provides Biofene for specialty chemical applications and transportation fuels, such as diesel. In addition, the company is involved in the development, production, and commercialization of renewable base oils, as well as additives and lubricants for the automotive, industrial, and commercial lubricants markets; and offers natural oils and aroma chemicals for the flavors and fragrances market. It has a strategic partnership with Total for the production and commercialization of diesel and jet fuels. The company was former

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding211.17 M EPS-6.31 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -15.42% Sales Growth - Q/Q-32.05% P/E-0.48
P/E To EPS Growth P/S1.87 P/BV-0.46 Price/Cash Per Share1.86
Price/Free Cash Flow-0.94 ROA-34.92% ROE36.34% ROI-54.44%
Current Ratio1.34 Quick Ratio1.12 Long Term Debt/Equity17.06 Debt Ratio-0.28
Gross Margin21.8% Operating Margin-217.94% Net Profit Margin-149.48% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities7.32 M Cash From Investing Activities-1.07 M Cash From Operating Activities-3.28 M Gross Profit1.23 M
Net Profit-52.24 M Operating Profit-25.16 M Total Assets193.05 M Total Current Assets69.3 M
Total Current Liabilities51.65 M Total Debt242.99 M Total Liabilities378.61 M Total Revenue7.87 M
Technical Data
High 52 week7.32 Low 52 week1.88 Last close3.77 Last change1.62%
RSI57.94 Average true range0.32 Beta1.29 Volume768.67 K
Simple moving average 20 days-2.24% Simple moving average 50 days-7.33% Simple moving average 200 days-3.09%
Performance Data
Performance Week1.62% Performance Month1.62% Performance Quart-7.14% Performance Half-10.45%
Performance Year2.45% Performance Year-to-date12.87% Volatility daily5.69% Volatility weekly12.72%
Volatility monthly26.07% Volatility yearly90.31% Relative Volume154.97% Average Volume804.48 K
New High New Low


2020-05-29 13:56:23 | Top Marijuana Stocks for June 2020

2020-05-21 09:18:00 | Amyris Launches Safe Alternative To Talc-Based Baby Powder

2020-05-17 20:00:00 | Is Another Accounting Issue Brewing for Amyris?

2020-05-15 08:30:00 | Amyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format

2020-05-14 09:36:00 | Is Amyris Finally Turning a Corner?

2020-05-14 08:30:00 | Amyris Receives GRAS Validation by Medical Expert Panel for its New Health and Nutrition Ingredient

2020-05-09 01:42:26 | Edited Transcript of AMRS earnings conference call or presentation 8-May-20 1:00pm GMT

2020-05-08 08:30:00 | Amyris, Inc. Reports First Quarter 2020 Results

2020-05-07 08:30:00 | Amyris to Participate in the Oppenheimer 5th Annual Emerging Growth Conference on May 12

2020-05-04 08:30:00 | Amyris To Host First Quarter 2020 Financial Results Conference Call On May 8

2020-04-21 19:10:00 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amyris, Inc.- AMRS

2020-04-20 08:30:00 | Amyris Receives Approval to Sell its Fermented Sugarcane Reb M in Brazil and Canada

2020-04-13 07:30:00 | Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family

2020-03-31 08:30:00 | Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products

2020-03-26 08:30:00 | Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant

2020-03-23 06:13:03 | Should You Worry About Amyris, Inc.'s NASDAQ:AMRS CEO Pay Cheque?

2020-03-16 08:05:00 | Amyris Provides Business Update

2020-03-13 11:17:01 | Edited Transcript of AMRS earnings conference call or presentation 12-Mar-20 8:30pm GMT

2020-03-12 16:15:00 | Amyris Reports Another Strong Quarter of Recurring Revenue Growth

2020-03-12 14:30:00 | Amyris, Inc. to Host Earnings Call

2020-03-10 08:30:00 | Amyris to Participate in Fireside Chat at 32nd Annual Roth Conference on March 16, 2020

2020-03-09 08:30:00 | Amyris Expands Distribution of PURECANE Baking Sweetener on Amazon ? Strong Early Sales

2020-03-06 08:30:00 | Amyris Discovers Major Breakthrough in CBD Delivery

2020-03-05 08:00:00 | Amyris to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Thursday, March 12

2020-03-03 08:30:00 | Amyris Introduces New PURECANEā„¢ Baking Sweetener Direct to Consumers on Purecane.com to Outperform Low-Calorie Competitors

2020-02-26 08:30:00 | Amyris to Present at Cowen 40th Annual Health Care Conference on March 3, 2020

2020-02-25 08:30:00 | Amyris Expands Distribution of PURECANEā„¢ Packets on Amazon

2020-02-23 17:23:01 | Largest Insider Trades of the Week

2020-02-19 08:30:00 | Amyris Provides Clean Beauty Business Update

2020-02-14 08:30:00 | Biossance Expands The Clean Academy ? The Ultimate Clean Beauty Resource

2020-02-13 08:30:00 | Amyris, Inc. Appoints Han Kieftenbeld As Chief Financial Officer

2020-02-07 05:29:39 | Insider Buying: The Amyris, Inc. NASDAQ:AMRS Independent Director Just Bought US$30m Worth Of Shares

2020-02-03 09:05:00 | Amyris Announces Execution of Definitive Agreements for up to an Anticipated $70 Million Debt Reduction Via Exercise of Existing Warrants and $42 Million in New Financing

2020-01-23 08:30:00 | Clean Beauty Leader Biossance Lands in the UK

2020-01-15 05:10:04 | How Does Amyris, Inc. NASDAQ:AMRS Affect Your Portfolio Volatility?

2020-01-13 08:44:01 | Options Traders Expect Huge Moves in Amyris AMRS Stock

2020-01-13 08:30:00 | Amyris Provides Update - Achieves Record Fourth-Quarter 2019 Product Shipments; Clean Beauty Produces Breakout Performance

2019-12-27 08:30:00 | Amyris Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates

2019-12-19 15:51:25 | Were Hedge Funds Right Dumping Amyris Inc AMRS?

2019-12-17 08:30:00 | WWD Beauty Inc Names Biossance Brand Digital Innovator Of The Year

2019-12-13 08:50:01 | Options Traders Expect Huge Moves in Amyris AMRS Stock

2019-12-12 16:52:00 | SHAREHOLDER NOTICE: Scott+Scott Attorneys at Law LLP Continues Investigating Amyris, Inc.'s Directors and Officers for Breach of Fiduciary Duty - AMRS

2019-12-10 06:05:39 | How Many Amyris, Inc. NASDAQ:AMRS Shares Did Insiders Buy, In The Last Year?

2019-12-04 08:30:00 | Biossance Leading the Clean Beauty Revolution with Biossance.com Cyber Monday Sales up over 3X from Last Year, Marking Highest One-Day Sales in Brand History

2019-11-25 08:30:00 | Amyris Engages 30-Year Wall Street Veteran to Support Capital Markets Activities & Further Balance Sheet Transformation

2019-11-19 08:30:00 | American Diabetes Association Announces Amyris CEO John Melo as Executive Committee Chair of 2020 Wine Country Tour de Cure

2019-11-18 13:03:03 | Top Marijuana Stocks for November 2019

2019-11-18 08:30:00 | Amyris Advances to Regulatory Stage with Another Significant Health & Nutrition Molecule

2019-11-15 16:07:00 | Amyris Closes on Exchange to Resolve CVI Heights Debt

2019-11-11 08:30:00 | Amyris Executes Agreements to Resolve CVI Heights Debt